Fuxiang Zhou, Lei Yang, Jin Peng, Hui Xu, Han Wu, You Wang, Xin Long, Qing Gao, Xiangru Shi, Jun Gong, Jinmin Hu. "The efficacy and safety of Surufatinib monotherapy as a third-line treatment for advanced hepatocellular carcinoma: A single-arm, open-label, multi-center phase II study.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e16209